Prediction of a positive result in rodent carcinogenesis bioassays using two instead of four sex‐species groups is examined for the subset of chemicals in the Carcinogenic Potency Database that have been tested in four sex‐species groups and are positive in at least one (n = 212). Under the conditions of these bioassays, a very high proportion of rodent carcinogens that are identified as positive by tests in four groups is also identified by results from one sex of each species (86–92%). Additionally, chemicals that are classified as “two‐species carcinogens” or “multiple‐site carcinogens” on the basis of results from four sex‐species groups are also identified as two‐species or multiple‐site carcinogens on the basis of two sex‐species groups. Carcinogenic potency (TD50) values for the most potent target site are similar when based on results from two compared to four sex‐species groups. Eighty‐five percent of the potency values are within a factor of 2 of those obtained from tests in 4 sex‐species groups, 94% are within a factor of 4, and 98% are within a factor of 10. This result is expected because carcinogenic potency values are constrained to a narrow range about the maximum dose tested in a bioassay, and the maximum doses administered to rats and mice are highly correlated and similar in dose level.